Validity of real time ultrasound in the diagnosis of hepatic steatosis: a prospective study
- PMID: 19846234
- PMCID: PMC6136148
- DOI: 10.1016/j.jhep.2009.09.001
Validity of real time ultrasound in the diagnosis of hepatic steatosis: a prospective study
Abstract
Background/aims: Ultrasound is used to screen for hepatic steatosis, the most common liver disease in the United States. However, few studies have prospectively evaluated the accuracy of ultrasound to diagnose hepatic steatosis. Therefore, a double blinded prospective study was performed in consecutive patients undergoing liver biopsy to evaluate the accuracy of ultrasound to diagnose hepatic steatosis.
Methods: Real time ultrasound was performed just prior to the biopsy by a single investigator masked to the clinical diagnosis. The liver biopsy was reviewed by a pathologist masked to the clinical indication or sonographic findings.
Results: Of 73 consecutive patients studied, macrovesicular steatosis of any severity on biopsy was found in 46 (63%) and micro vesicular fat found in 51 (69.9%). The overall impression of the sonographer for the presence of macrovesicular hepatic steatosis of any degree had a sensitivity of 60.9% and a specificity of 100%. The sensitivity increased to 100% and the specificity to 90% when there was > or =20% of fat. The zonular distribution of the fat did not alter the diagnostic accuracy of ultrasound. Ultrasound had a poor yield in the diagnosis of microvesicular fat with an overall sensitivity of 43% and a specificity of 73%. The combination of increased echogenicity and portal vein blurring on ultrasound had the greatest sensitivity in the diagnosis of hepatic steatosis.
Conclusion: Real time ultrasound using a combination of sonographic findings has a high specificity but underestimates the prevalence of hepatic steatosis when there is<20% fat.
Figures
Similar articles
-
Hepatic MRI for fat quantitation: its relationship to fat morphology, diagnosis, and ultrasound.J Clin Gastroenterol. 2005 Aug;39(7):619-25. doi: 10.1097/00004836-200508000-00012. J Clin Gastroenterol. 2005. PMID: 16000931
-
Assessment of hepatic steatosis by using attenuation imaging: a quantitative, easy-to-perform ultrasound technique.Eur Radiol. 2019 Dec;29(12):6499-6507. doi: 10.1007/s00330-019-06272-y. Epub 2019 Jun 7. Eur Radiol. 2019. PMID: 31175413
-
Evaluation of hepatic steatosis by ultrasound in patients with chronic hepatitis C virus infection.Liver Int. 2007 Aug;27(6):748-57. doi: 10.1111/j.1478-3231.2007.01491.x. Liver Int. 2007. PMID: 17617117
-
Noninvasive assessment of hepatic steatosis.Clin Gastroenterol Hepatol. 2009 Feb;7(2):135-40. doi: 10.1016/j.cgh.2008.11.023. Epub 2008 Dec 6. Clin Gastroenterol Hepatol. 2009. PMID: 19118644 Free PMC article. Review.
-
Non-alcoholic steatohepatitis in children.Pediatr Transplant. 2004 Dec;8(6):613-8. doi: 10.1111/j.1399-3046.2004.00241.x. Pediatr Transplant. 2004. PMID: 15598336 Review.
Cited by
-
Prunus mume extract and choline treatment in patients with non-alcoholic fatty liver disease estimated by b-mode ultrasonography and hepatorenal index.Caspian J Intern Med. 2024 Winter;15(1):161-171. doi: 10.22088/cjim.15.1.19. Caspian J Intern Med. 2024. PMID: 38463914 Free PMC article.
-
Continuous age- and sex-specific reference ranges of liver enzymes in Chinese children and application in pediatric non-alcoholic fatty liver disease.World J Pediatr. 2024 Feb 22. doi: 10.1007/s12519-023-00789-5. Online ahead of print. World J Pediatr. 2024. PMID: 38388968
-
Non-alcoholic fatty liver disease in patients with morbid obesity: the gut microbiota axis as a potential pathophysiology mechanism.J Gastroenterol. 2024 Jan 24. doi: 10.1007/s00535-023-02075-7. Online ahead of print. J Gastroenterol. 2024. PMID: 38265508
-
Liver and atherosclerotic risks of patients with cryptogenic steatotic liver disease.Hepatol Int. 2024 Jan 16. doi: 10.1007/s12072-023-10624-8. Online ahead of print. Hepatol Int. 2024. PMID: 38227142
-
Development and Validation of a Risk Prediction Model for NAFLD: A Study Based on a Physical Examination Population.Diabetes Metab Syndr Obes. 2024 Jan 8;17:143-155. doi: 10.2147/DMSO.S438652. eCollection 2024. Diabetes Metab Syndr Obes. 2024. PMID: 38222035 Free PMC article.
References
-
- Tarantino G Non-alcoholic fatty liver disease, obesity and other illnesses. Clin Invest Med 2008;31 :E290–E295. - PubMed
-
- Torres DM, Harrison SA. Diagnosis and therapy of nonalcoholic steatohepatities. Gastroenterology 2008; 134:1682–1698. - PubMed
-
- Perez NE, Siddiqui FA, Mutchnick MG, Dhar R, Tobi M, Ullah N, et al. Ultrasound diagnosis of fatty liver in patients with chronic liver disease: a retrospective observational study. J Clin Gastroenterol 2007;41:624–629. - PubMed
-
- Strauss S, Gavish E, Gottlieb P, Katsnelson L. Interobserver and intraobserver variability in the sonographic assessment of fatty liver. AJR Am J Roentgenol 2007; 189:W320–W323. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
